PNV-First - 42192-350-30 - (.beta.-carotene, cholecalciferol, ascorbic acid, .alpha.-tocopherol acetate, dl-, folic acid, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, niacinamide, calcium carbonate, ferrous fumarate, magnesium oxide, zinc oxide, cupric oxide and doconexent)

Alphabetical Index


Drug Information of PNV-First

Product NDC: 42192-350
Proprietary Name: PNV-First
Non Proprietary Name: .beta.-carotene, cholecalciferol, ascorbic acid, .alpha.-tocopherol acetate, dl-, folic acid, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, niacinamide, calcium carbonate, ferrous fumarate, magnesium oxide, zinc oxide, cupric oxide and doconexent
Active Ingredient(s): 20; 1100; 30; 1000; 2; 12; 1; 29; 20; 15; 200; 150; 2.5; 1.8; 1.6; 25    [iU]/1; [iU]/1; mg/1; [iU]/1; mg/1; ug/1; mg/1; mg/1; mg/1; mg/1; mg/1; ug/1; mg/1; mg/1; mg/1; mg/1 & nbsp;   .beta.-carotene, cholecalciferol, ascorbic acid, .alpha.-tocopherol acetate, dl-, folic acid, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, niacinamide, calcium carbonate, ferrous fumarate, magnesium oxide, zinc oxide, cupric oxide and doconexent
Administration Route(s): ORAL
Dosage Form(s): TABLET, COATED
Coding System: National Drug Codes(NDC)

Labeler Information of PNV-First

Product NDC: 42192-350
Labeler Name: Acella Pharmaceuticals, LLC
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number:
Marketing Category: UNAPPROVED DRUG OTHER
Start Marketing Date: 20130517

Package Information of PNV-First

Package NDC: 42192-350-30
Package Description: 30 TABLET, COATED in 1 BOTTLE (42192-350-30)

NDC Information of PNV-First

NDC Code 42192-350-30
Proprietary Name PNV-First
Package Description 30 TABLET, COATED in 1 BOTTLE (42192-350-30)
Product NDC 42192-350
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name .beta.-carotene, cholecalciferol, ascorbic acid, .alpha.-tocopherol acetate, dl-, folic acid, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, niacinamide, calcium carbonate, ferrous fumarate, magnesium oxide, zinc oxide, cupric oxide and doconexent
Dosage Form Name TABLET, COATED
Route Name ORAL
Start Marketing Date 20130517
Marketing Category Name UNAPPROVED DRUG OTHER
Labeler Name Acella Pharmaceuticals, LLC
Substance Name .ALPHA.-TOCOPHEROL ACETATE, DL-; .BETA.-CAROTENE; ASCORBIC ACID; CHOLECALCIFEROL; CUPRIC OXIDE; CYANOCOBALAMIN; FOLIC ACID; IRON SUCROSE; MAGNESIUM OXIDE; NIACINAMIDE; OMEGA-3 FATTY ACIDS; POTASSIUM IODIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN; THIAMINE MONONITRATE; ZINC OXIDE
Strength Number 20; 1100; 30; 1000; 2; 12; 1; 29; 20; 15; 200; 150; 2.5; 1.8; 1.6; 25
Strength Unit [iU]/1; [iU]/1; mg/1; [iU]/1; mg/1; ug/1; mg/1; mg/1; mg/1; mg/1; mg/1; ug/1; mg/1; mg/1; mg/1; mg/1
Pharmaceutical Classes Vitamin B 12 [Chemical/Ingredient],Vitamin B12 [EPC],Calculi Dissolution Agent [EPC],Magnesium Ion Exchange Activity [MoA],Fatty Acids, Omega-3 [Chemical/Ingredient],Omega-3 Fatty Acid [EPC],Vitamin D [Chemical/Ingredient],Vitamin D [EPC]

Complete Information of PNV-First


General Information